TARO logo

Taro Pharmaceutical Industries (TARO) Non Current Assets

Annual Non Current Assets

$858.67 M
+$59.58 M+7.46%

31 March 2024

TARO Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$858.67 M
+$42.89 M+5.26%

31 March 2024

TARO Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TARO Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.5%+10.5%
3 y3 years-8.3%-5.1%
5 y5 years+31.6%+11.5%

TARO Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-8.3%-8.3%

Taro Pharmaceutical Industries Non Current Assets History

DateAnnualQuarterly
Mar 2024
$1.30 B(-2.5%)
$858.67 M(+5.3%)
Dec 2023
-
$815.77 M(+5.0%)
Sept 2023
-
$776.92 M(-7.6%)
June 2023
-
$840.88 M(+5.2%)
Mar 2023
$1.34 B(-0.1%)
$799.09 M(+6.4%)
Sept 2022
-
$750.67 M(-2.7%)
June 2022
-
$771.73 M(-8.0%)
Mar 2022
$1.34 B(-9.0%)
$838.48 M(-5.3%)
Dec 2021
-
$885.78 M(-2.1%)
Sept 2021
-
$905.21 M(-2.9%)
June 2021
-
$932.54 M(-0.4%)
Mar 2021
$1.47 B(-4.0%)
$936.04 M(+10.2%)
Dec 2020
-
$849.55 M(-1.2%)
Sept 2020
-
$860.28 M(+0.4%)
June 2020
-
$856.76 M(+5.9%)
Mar 2020
$1.53 B(+3.4%)
$808.65 M(-3.0%)
Dec 2019
-
$833.25 M(+8.2%)
Sept 2019
-
$769.84 M(+20.6%)
June 2019
-
$638.54 M(-2.2%)
Mar 2019
$1.48 B(-21.8%)
$652.61 M(+7.4%)
Dec 2018
-
$607.77 M(-12.0%)
Sept 2018
-
$690.50 M(+7.1%)
June 2018
-
$644.69 M(+20.1%)
Mar 2018
$1.90 B(-5.1%)
$536.58 M(+4.2%)
Dec 2017
-
$514.97 M(+5.8%)
Sept 2017
-
$486.73 M(+14.9%)
June 2017
-
$423.59 M(+45.7%)
Mar 2017
$2.00 B(+6.5%)
$290.73 M(-37.5%)
Dec 2016
-
$465.30 M(-18.6%)
Sept 2016
-
$571.74 M(+18.3%)
June 2016
-
$483.20 M(+55.7%)
Mar 2016
$1.88 B(+24.0%)
$310.44 M(+51.2%)
Dec 2015
-
$205.30 M(+6.3%)
Sept 2015
-
$193.07 M(-11.5%)
June 2015
-
$218.07 M(-2.6%)
Mar 2015
$1.51 B(+44.0%)
$223.94 M(-9.5%)
Dec 2014
-
$247.44 M(+6.1%)
Sept 2014
-
$233.16 M(-7.5%)
June 2014
-
$252.06 M(+8.1%)
Mar 2014
$1.05 B(+15.6%)
$233.10 M(+2.8%)
Dec 2013
-
$226.66 M(+15.9%)
Sept 2013
-
$195.54 M(+0.4%)
June 2013
-
$194.80 M(-1.0%)
Mar 2013
$909.77 M(+39.2%)
$196.87 M(-3.3%)
Dec 2012
-
$203.64 M(+4.1%)
Sept 2012
-
$195.56 M(-1.0%)
June 2012
-
$197.47 M(-2.6%)
Mar 2012
$653.66 M(+12.4%)
$202.76 M(-5.4%)
Dec 2011
$581.43 M(+96.7%)
$214.41 M(-5.0%)
Sept 2011
-
$225.69 M(-6.5%)
June 2011
-
$241.31 M(-4.6%)
Mar 2011
-
$252.86 M(-3.0%)
Dec 2010
$295.64 M(+2.1%)
$260.81 M(+13.1%)
Sept 2010
-
$230.65 M(+2.1%)
June 2010
-
$225.92 M(-21.1%)
Dec 2009
$289.50 M
$286.38 M(+17.5%)
Sept 2009
-
$243.76 M(+4.4%)
June 2009
-
$233.58 M(-0.4%)
DateAnnualQuarterly
Mar 2009
-
$234.50 M(-4.9%)
Dec 2008
$226.63 M(+8.7%)
$246.47 M(-6.2%)
Sept 2008
-
$262.64 M(-25.1%)
Dec 2007
$208.42 M(+56.2%)
-
Dec 2006
$133.40 M(-32.5%)
-
Dec 2005
$197.52 M(-40.7%)
$350.69 M(-9.5%)
Sept 2005
-
$387.47 M(+2.0%)
June 2005
-
$379.95 M(-0.4%)
Mar 2005
-
$381.39 M(+4.9%)
Dec 2004
$333.11 M(-13.2%)
$363.73 M(+4.6%)
Sept 2004
-
$347.58 M(+16.6%)
June 2004
-
$297.98 M(+7.9%)
Mar 2004
-
$276.16 M(+18.6%)
Dec 2003
$383.69 M(+49.2%)
$232.83 M(+17.1%)
Sept 2003
-
$198.82 M(+5.4%)
June 2003
-
$188.64 M(+9.8%)
Mar 2003
-
$171.74 M(+39.9%)
Dec 2002
$257.12 M(+11.1%)
$122.73 M(+14.4%)
Sept 2002
-
$107.33 M(+13.0%)
June 2002
-
$94.94 M(+16.7%)
Mar 2002
-
$81.33 M(+6.6%)
Dec 2001
$231.49 M(+222.7%)
$76.27 M(+31.5%)
Sept 2001
-
$57.99 M(+7.1%)
June 2001
-
$54.13 M(+4.8%)
Mar 2001
-
$51.63 M(+6.0%)
Dec 2000
$71.74 M(+41.4%)
$48.71 M(+9.9%)
Sept 2000
-
$44.31 M(+2.4%)
June 2000
-
$43.25 M(+3.0%)
Mar 2000
-
$41.98 M(+4.3%)
Dec 1999
$50.73 M(+27.8%)
$40.23 M(+5.6%)
Sept 1999
-
$38.10 M(+2.1%)
June 1999
-
$37.30 M(+6.3%)
Mar 1999
-
$35.10 M(+0.7%)
Dec 1998
$39.70 M(+5.6%)
$34.87 M(-1.2%)
Mar 1998
-
$35.30 M(+3.5%)
Dec 1997
$37.60 M(+13.9%)
$34.10 M(+12.2%)
Sept 1997
-
$30.40 M(0.0%)
June 1997
-
$30.40 M(+2.7%)
Mar 1997
-
$29.60 M(+2.4%)
Dec 1996
$33.00 M(+18.3%)
$28.90 M(+9.5%)
Sept 1996
-
$26.40 M(+6.0%)
June 1996
-
$24.90 M(+8.7%)
Mar 1996
-
$22.90 M(+6.0%)
Dec 1995
$27.90 M(+11.6%)
$21.60 M(+21.3%)
Dec 1994
$25.00 M(+41.2%)
$17.80 M(+10.6%)
Dec 1993
$17.70 M(+17.2%)
$16.10 M(+53.3%)
Dec 1992
$15.10 M(+49.5%)
$10.50 M(+45.8%)
Sept 1992
-
$7.20 M(+9.1%)
June 1992
-
$6.60 M(+24.5%)
Mar 1992
-
$5.30 M(+15.2%)
Dec 1991
$10.10 M(+44.3%)
$4.60 M(-2.1%)
Sept 1991
-
$4.70 M(+4.4%)
June 1991
-
$4.50 M(+7.1%)
Mar 1991
-
$4.20 M(0.0%)
Dec 1990
$7.00 M(+25.0%)
$4.20 M(+5.0%)
Mar 1990
-
$4.00 M(0.0%)
Dec 1989
$5.60 M(+19.1%)
$4.00 M(+25.0%)
Dec 1988
$4.70 M(+4.4%)
$3.20 M(+14.3%)
Dec 1987
$4.50 M
$2.80 M

FAQ

  • What is Taro Pharmaceutical Industries annual long term assets?
  • What is the all time high annual non current assets for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries annual non current assets year-on-year change?
  • What is Taro Pharmaceutical Industries quarterly long term assets?
  • What is the all time high quarterly non current assets for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries quarterly non current assets year-on-year change?

What is Taro Pharmaceutical Industries annual long term assets?

The current annual non current assets of TARO is $858.67 M

What is the all time high annual non current assets for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high annual long term assets is $936.04 M

What is Taro Pharmaceutical Industries annual non current assets year-on-year change?

Over the past year, TARO annual long term assets has changed by +$59.58 M (+7.46%)

What is Taro Pharmaceutical Industries quarterly long term assets?

The current quarterly non current assets of TARO is $858.67 M

What is the all time high quarterly non current assets for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high quarterly long term assets is $936.04 M

What is Taro Pharmaceutical Industries quarterly non current assets year-on-year change?

Over the past year, TARO quarterly long term assets has changed by +$81.75 M (+10.52%)